<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05010070</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00154361</org_study_id>
    <nct_id>NCT05010070</nct_id>
  </id_info>
  <brief_title>The University of Michigan Wellness for Liver Health Study</brief_title>
  <official_title>The University of Michigan Wellness Education for Liver Health Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this proposal is to pilot test our existing very-low carbohydrate diet&#xD;
      intervention, adapted for adults with Non-alcoholic Fatty Liver Disease (NAFLD).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As there are no medications that effectively treat nonalcoholic fatty liver disease (NAFLD),&#xD;
      effective diet and lifestyle treatments are imperative to curb this disease's impact. Our&#xD;
      data suggests that insulin resistance is the strongest modifiable risk factor for having&#xD;
      NAFLD. Additionally, genetic factors can interact with insulin resistance to multiplicatively&#xD;
      increase risk of NAFLD. The investigators hypothesize that a very low-carbohydrate diet and&#xD;
      behavioral support program may be able to achieve NAFLD reversal in adults with steatosis&#xD;
      and/or mild fibrosis, especially in a subpopulation of rs738409-GG individuals. To prepare to&#xD;
      test this, the investigators will conduct a pilot feasibility and acceptability trial of a&#xD;
      4-month online very low-carbohydrate, ketogenic (or keto) program in adults with NAFLD.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 31, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2022</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in liver fat content using liver MRI-derived proton density fat fraction</measure>
    <time_frame>4 months</time_frame>
    <description>Measured with pre and post MRIs</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in MRI-based liver fibrosis</measure>
    <time_frame>4 months</time_frame>
    <description>Measured with pre and post MRIs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent body weight change</measure>
    <time_frame>4 months</time_frame>
    <description>Measured with change in body weight</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Nonalcoholic Fatty Liver Disease</condition>
  <arm_group>
    <arm_group_label>diet and lifestyle program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be taught how to follow a very low carbohydrate, ketogenic diet, become more physically active, and get adequate sleep. They will also be taught about positive affect skills (such as gratitude, positive reappraisal, and personal strengths) and mindful eating.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>diet and lifestyle program</intervention_name>
    <description>See description of main arm.</description>
    <arm_group_label>diet and lifestyle program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  have regular access to the internet&#xD;
&#xD;
          -  MRI with liver steatosis but nor cirrhosis&#xD;
&#xD;
          -  Able to consent and follow directions&#xD;
&#xD;
          -  No physical limitations&#xD;
&#xD;
          -  Physician approval to participate&#xD;
&#xD;
          -  Able to attend in-person appointments in Ann Arbor&#xD;
&#xD;
          -  Be identified based on information from the Michigan Genomics Initiative (MGI)&#xD;
             database&#xD;
&#xD;
          -  have elevated liver function tests&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  non-English speaking&#xD;
&#xD;
          -  inability to complete baseline measurements&#xD;
&#xD;
          -  a substance abuse, mental health, or medical condition that would interfere with&#xD;
             participation (such as current chemotherapy, heart failure, kidney failure, Cushing's&#xD;
             syndrome, etc.)&#xD;
&#xD;
          -  pregnant or planning to get pregnant in the next 6 months&#xD;
&#xD;
          -  type 1 diabetes&#xD;
&#xD;
          -  non-NAFLD causes of elevated liver function tests&#xD;
&#xD;
          -  planned or history of weight loss surgery&#xD;
&#xD;
          -  vegan or vegetarian&#xD;
&#xD;
          -  currently enrolled in a weight loss program or other investigative study that might&#xD;
             conflict with this research&#xD;
&#xD;
          -  taking medications known to cause weight gain or loss&#xD;
&#xD;
          -  recent decompensation/hospitalization&#xD;
&#xD;
          -  metal implants/inability to receive MRI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laura Saslow, PhD</last_name>
    <phone>734-764-7836</phone>
    <email>saslowl@umich.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alison O'Brien, MPH</last_name>
    <phone>734-763-1997</phone>
    <email>alisonob@umich.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alison O'Brien</last_name>
      <phone>734-763-1997</phone>
      <email>alisonob@umich.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 10, 2021</study_first_submitted>
  <study_first_submitted_qc>August 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 18, 2021</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Laura Saslow</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>nutrition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

